Douglas E. Williams, EVP Research & Development at BIOGEN IDEC INC. (BIIB), sold 3,505 shares at $352.29 ($1.2M) on 2014-03-19, disclosed to the SEC on 2014-03-21.
Scheduled sale ($1.2M) by EVP Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $352.29 | 916 | $323K | 26.1% |
| 2 | $352.29 | 994 | $350K | 28.4% |
| 3 | $352.29 | 1,595 | $562K | 45.5% |
| Total | $352.29 avg | 3,505 | $1.2M | 100% |
| Filing → |
| CDAK | SELL | 2023-01-23 | $3K | — | Filing → |
| OVID | BUY | 2018-08-16 | $32K | — | Filing → |
| BIIB | SELL | 2015-06-22 | $1.6M | — | Filing → |